Bausch Health Companies (BHC) EPS (Basic) (QoQ) (2009 - 2026)
Bausch Health Companies (BHC) EPS (Basic) (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Bausch Health Companies | 2.57 Bn | 734.50 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 118.06% |
| Mar 31, 2026 | -1,282.24% |
| Dec 31, 2025 | -156.97% |
| Sep 30, 2025 | 41.25% |
| Jun 30, 2025 | 248.32% |
| Mar 31, 2025 | -187.38% |
| Dec 31, 2024 | 206.64% |
| Sep 30, 2024 | -9,087.51% |
| Jun 30, 2024 | 98.71% |
| Mar 31, 2024 | -62.98% |
| Dec 31, 2023 | 87.68% |
| Sep 30, 2023 | -1,512.49% |
| Jun 30, 2023 | 112.87% |
| Mar 31, 2023 | 49.21% |
| Dec 31, 2022 | -201.88% |
| Sep 30, 2022 | 389.69% |
| Jun 30, 2022 | -109.79% |
| Mar 31, 2022 | -191.18% |
| Dec 31, 2021 | -62.23% |
| Sep 30, 2021 | 132.16% |